![]() |
|
||
|
![]() ![]() ![]() ![]()
![]() ![]() ![]() ![]() ![]()
![]() ![]() ![]() ![]() ![]()
![]() ![]() ![]() ![]() ![]()
|
Research Mission
• an assessment of illness severity and variability over time with the end goal of demonstrating that there is a predictable rhythm to when patients experience insomnia and that this is fundamentally related to how sleep is homeostatically regulated. • the placebo effect as it occurs in insomnia clinical trials and how the episodic nature of insomnia may interact with pill use to 1) reinforce and sustain placebo-related clinical gains and 2) result in increased clinical gains via conditioning. • the use of partial reinforcement schedules during long term therapy with hypnotics to sustain clinical gains while reducing the amount of medication used to achieve clinical gains. • an assessment of the effectiveness of CBT-I for insomnia secondary to chronic pain and insomnia secondary to cancer • the development of a risk factor model for insomnia so that the natural course of the disorder can be empirically assessed.
Long Term GoalsCollaborative
Ventures
|
|